Company intelligence / Profile preview

Pioneer Pharma

Hong Kong, Hong Kong

Ownership: Private
Development stage: Other

Overview

The company operates as a distributor and marketer of established pharmaceutical products and medical devices rather than conducting clinical development. The parent company reported revenue of RMB817.5 million for the first half of 2024, with pharmaceutical products representing 30.4% and medical devices representing 52.3% of total revenue.

Therapeutic areas: CardiovascularImmunologyOphthalmologyGastroenterologyNeurologyWomen's HealthOtherDermatology
Modalities: Small moleculeMedical deviceBiologic
Industry: Investors

Partnerships

AlconAlfasigmaAenovaPolichemFleetIvoclar VivadentWielandNovaBay

Beyond the preview

Go deeper on Pioneer Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pioneer Pharma.

Explore the full profile